Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
1(20.0%)
Phase 3
1(20.0%)
5Total
N/A(3)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01334775Not ApplicableTerminated

Comparison of Self-adhering Mesh and Conventional Mesh in Inguinal Hernia Repair.

Role: collaborator

NCT02218502Not ApplicableTerminated

Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses

Role: collaborator

NCT02326038Phase 4Unknown

Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study

Role: collaborator

NCT01398644Phase 3Unknown

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients

Role: collaborator

NCT00940719Not ApplicableCompleted

Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)

Role: collaborator

All 5 trials loaded